Literature DB >> 19444481

Imaging studies for first urinary tract infection in infants less than 6 months old: can they be more selective?

Niko Kei-chiu Tse1, Sandy Lai-kei Yuen, Man-chun Chiu, Wai-ming Lai, Pak-chiu Tong.   

Abstract

This retrospective study aimed to evaluate the applicability of the selective approach of imaging infants < 6 months old with urinary tract infection (UTI) according to the UTI guidelines of the National Institute for Health and Clinical Excellence (NICE) 2007. Infants < 6 months old with their first UTI from January 2001 to December 2006 having undergone an ultrasound examination of the urinary tract, a micturating cystourethrogram, and a late di-mercaptosuccinic acid (DMSA) scan, were included. Their condition was evaluated against a set of risk features according to the UTI guidelines. Those having any one of these were classified as atypical and those having none as typical. There were 134 infants reviewed, with a typical (98 infants) to atypical (36 infants) ratio of 2.7 to 1. Girls were found to be relatively more represented in the atypical group [male (M):female (F) = 1.3:1] than in the typical group (M:F = 4.4:1) (P < 0.004). There were significantly more infants with abnormal micturating voiding cystourethrograms (MCUGs) (P = 0.007), more refluxing ureters (P < 0.001) and more significant vesico-ureteral reflux (VUR) (>/= grade III) (P = 0.013) in the atypical group than in the typical group; while there was no significant difference in ultrasound (US) and DMSA scan findings between the two groups. In the atypical group there was no difference in imaging studies (and, thus, the results) between the conventional practice and the NICE UTI recommendation. In the typical group, if the recommendations of the guidelines had been followed (i.e. only those with abnormal US would have been further investigated), 25 refluxing ureters and 22 scarred kidneys would have been left undiagnosed. In conclusion, application of the suggested selective imaging approach would leave a significant number of VUR and renal scars undiagnosed, and it may not be an optimal practice for infants less than 6 months old with their first UTI. The best approach remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444481     DOI: 10.1007/s00467-009-1203-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  The presence of vesicoureteric reflux does not identify a population at risk for renal scarring following a first urinary tract infection.

Authors:  I Moorthy; M Easty; K McHugh; D Ridout; L Biassoni; I Gordon
Journal:  Arch Dis Child       Date:  2005-07       Impact factor: 3.791

2.  Does a normal DMSA obviate the performance of voiding cystourethrography in evaluation of young children after their first urinary tract infection?

Authors:  Min-Hua Tseng; Wei-Jen Lin; Wen-Tsung Lo; Sheng-Ru Wang; Mong-Ling Chu; Chih-Chien Wang
Journal:  J Pediatr       Date:  2007-01       Impact factor: 4.406

Review 3.  Long-term consequences of urinary tract infections.

Authors:  S Hellerstein
Journal:  Curr Opin Pediatr       Date:  2000-04       Impact factor: 2.856

4.  Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children.

Authors:  Svante Swerkersson; Ulf Jodal; Rune Sixt; Eira Stokland; Sverker Hansson
Journal:  J Urol       Date:  2007-06-15       Impact factor: 7.450

5.  Dimercaptosuccinic acid (DMSA) renal scan in the evaluation of hypertension in children.

Authors:  Maheen Ahmed; Daniel Eggleston; Gaurav Kapur; Amrish Jain; Rudolph P Valentini; Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2007-11-20       Impact factor: 3.714

Review 6.  Imaging and treatment strategies for children after first urinary tract infection.

Authors:  Ron Keren
Journal:  Curr Opin Pediatr       Date:  2007-12       Impact factor: 2.856

7.  Normal dimercaptosuccinic acid scintigraphy makes voiding cystourethrography unnecessary after urinary tract infection.

Authors:  Iulian Preda; Ulf Jodal; Rune Sixt; Eira Stokland; Sverker Hansson
Journal:  J Pediatr       Date:  2007-08-06       Impact factor: 4.406

8.  Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study.

Authors:  Eduardo H Garin; Fernando Olavarria; Victor Garcia Nieto; Blanca Valenciano; Alfonso Campos; Linda Young
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

9.  Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study.

Authors:  G Roussey-Kesler; V Gadjos; N Idres; B Horen; L Ichay; M D Leclair; F Raymond; A Grellier; I Hazart; L de Parscau; R Salomon; G Champion; V Leroy; V Guigonis; D Siret; J B Palcoux; S Taque; A Lemoigne; J M Nguyen; C Guyot
Journal:  J Urol       Date:  2007-12-20       Impact factor: 7.450

10.  Guidelines for the management of acute urinary tract infection in childhood. Report of a Working Group of the Research Unit, Royal College of Physicians.

Authors: 
Journal:  J R Coll Physicians Lond       Date:  1991-01
View more
  10 in total

Review 1.  Urinary tract infections in children: recommendations for antibiotic prophylaxis and evaluation. An evidence-based approach.

Authors:  Paul A Merguerian; Einar F Sverrisson; Daniel B Herz; Leslie T McQuiston
Journal:  Curr Urol Rep       Date:  2010-03       Impact factor: 3.092

2.  Paediatric urinary tract infections: a retrospective application of the National Institute of Clinical Excellence guidelines to a large general practitioner referred historical cohort.

Authors:  Kirsteen McDonald; Ian Kenney
Journal:  Pediatr Radiol       Date:  2014-05-01

3.  Evaluating different imaging strategies in children after first febrile urinary tract infection.

Authors:  Sik-Nin Wong; Niko Kei-Chiu Tse; Kwok-Piu Lee; So-Fun Yuen; Lettie Chuk-Kwan Leung; Benjamin Chee-Kit Pau; Winnie Kwai-Yu Chan; Kwok-Wai Lee; Hon-Ming Cheung; Stella Chim; Cynthia Mung-Sze Yip
Journal:  Pediatr Nephrol       Date:  2010-06-17       Impact factor: 3.714

Review 4.  Febrile urinary tract infection, vesicoureteral reflux, and renal scarring: current controversies in approach to evaluation.

Authors:  Martin A Koyle; Jack S Elder; Steven J Skoog; Tej K Mattoo; Hans G Pohl; Pramod P Reddy; Jennifer M Abidari; Warren T Snodgrass
Journal:  Pediatr Surg Int       Date:  2011-02-09       Impact factor: 1.827

5.  NICE guidelines for imaging studies in children with UTI adequate only in boys under the age of 6 months.

Authors:  Marko Tapani Ristola; Timo Hurme
Journal:  Pediatr Surg Int       Date:  2013-01-13       Impact factor: 1.827

6.  [Diagnostics and therapy of urinary tract infections].

Authors:  R Beetz; F Wagenlehner
Journal:  Urologe A       Date:  2013-01       Impact factor: 0.639

7.  Incidence of abnormal imaging and recurrent pyelonephritis after first febrile urinary tract infection in children 2 to 24 months old.

Authors:  Trisha M Juliano; Heidi A Stephany; Douglass B Clayton; John C Thomas; John C Pope; Mark C Adams; John W Brock; Stacy T Tanaka
Journal:  J Urol       Date:  2013-01-23       Impact factor: 7.450

Review 8.  Dimercaptosuccinic acid scan or ultrasound in screening for vesicoureteral reflux among children with urinary tract infections.

Authors:  Nader Shaikh; Russell B Spingarn; Stephanie W Hum
Journal:  Cochrane Database Syst Rev       Date:  2016-07-05

Review 9.  Managing urinary tract infections.

Authors:  Sermin A Saadeh; Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2011-03-16       Impact factor: 3.714

10.  Guidelines for the medical management of pediatric vesicoureteral reflux.

Authors:  Hideshi Miyakita; Yutaro Hayashi; Takahiko Mitsui; Manabu Okawada; Yoshiaki Kinoshita; Takahisa Kimata; Yasuhiro Koikawa; Kiyohide Sakai; Hiroyuki Satoh; Masatoshi Tokunaga; Yasuyuki Naitoh; Fumio Niimura; Hirofumi Matsuoka; Kentaro Mizuno; Kazunari Kaneko; Masayuki Kubota
Journal:  Int J Urol       Date:  2020-04-01       Impact factor: 3.369

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.